News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
34 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (15)
2 (105)
3 (184)
4 (160)
5 (95)
6 (86)
9 (195)
10 (158)
11 (164)
12 (134)
13 (88)
16 (146)
17 (115)
18 (154)
19 (154)
20 (84)
23 (128)
24 (33)
25 (4)
26 (8)
27 (6)
29 (16)
30 (34)
31 (32)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
29
30
31
Press Releases
European Commission approves RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
December 30, 2024
·
16 min read
Press Releases
Orion and Marinus terminate agreement for ganaxolone in Europe
December 30, 2024
·
1 min read
Press Releases
Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
December 30, 2024
·
4 min read
Press Releases
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
December 30, 2024
·
5 min read
Press Releases
Evaxion announces plan to implement ADS ratio change
December 30, 2024
·
4 min read
Press Releases
RenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy Platform
December 30, 2024
·
11 min read
Press Releases
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
·
5 min read
Press Releases
CardioSight, Inc appoints Niv Ad, M.D. as Chief Medical Officer
December 30, 2024
·
3 min read
Press Releases
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
December 30, 2024
·
4 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
1 of 4
Next